肝細胞がんにおけるアテゾリズマブ-ベバシズマブの実用的な結果: 将来のフランス CHIEF コホート
Manon Allaire1, Elhadji Malick Thiam2, Guiliana Amaddeo3
1AP-HP Sorbonne Université, Hôpital Universitaire Pitié-Salpêtrière, Service D'hépato-gastroentérologie, Paris, France.
まとめ
アテゾリズマブ- ベバシズマブ (AtezoBev) は,非ウイルス性肝臓疾患を含むフランスの肝細胞癌 (HCC) 患者で有効性を示しています. 臨床試験における生存率と反応率の比較が現実世界でのデータで確認されています.
科学分野:
- ヘパトロジー
- 医療腫瘍学
- 臨床研究
背景:
- アテゾリズマブ- ベバシズマブ (AtezoBev) は肝細胞癌 (HCC) の主要な免疫療法です.
- 初期の研究は,ウイルス関連のHCCに焦点を当てた.様々な病因における実際の有効性は極めて重要です.
- CHIEFコホートでは,様々な原因によるフランスのHCC集団におけるAtezoBevに関するデータを提供している.
研究 の 目的:
- フランスにおけるHCCの第一線治療としてのAtezoBevの実効性を評価する.
- 主に非ウイルス性HCC集団における生存結果 (OS,PFS) を評価する.
- AtezoBev 治療に対するベースライン特性の影響を分析する.
主な方法:
- CHIEFコホートにおける545人のHCC患者からの将来的なデータ収集 (2020年7月 - 2023年1月).
- 総合生存率 (OS) と無進行生存率 (PFS) のカプラン- メイヤー分析
- ログランクテストは,患者におけるベースライン因子の有意性を決定する.
主要な成果:
- 12ヶ月の生存率は66%でした.
- BCLC- BとChild- Pugh Aの患者で好ましいOSとPFSが観察されました.
- 肝疾患の病因は主にアルコール (30%) または混合 (58%) で,ウイルス病因は16%でした.
結論:
- CHIEFコホートからの現実世界のデータは,フランスのHCC患者におけるAtezoBevの有効性を確認しています.
- 生存率と応答率は,ピボタル試験のIMbrave150と比較できます.
- AtezoBevは,様々なHCCプロファイルに対する,通常の臨床実務における有効な治療法として検証されています.
さらに関連する動画
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.4K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
593
関連する概念動画
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Survival Analysis
445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
